Sakurada T, Alufuzoff I, Winblad B, Nordberg A
Department of Pharmacology, Tohoka College of Pharmacy, Sendai, Japan.
Brain Res. 1990 Jun 25;521(1-2):329-32. doi: 10.1016/0006-8993(90)91561-t.
Substance P-like immunoreactivity, choline acetyltransferase (ChAT) activity and muscarinic cholinergic receptors were measured in brains from 9 individuals with senile dementia of the Alzheimer type (AD), 4 individuals with multi-infarct dementia (MID), 6 individuals with mixed type of dementia (AD/MID) and 9 controls. The ChAT activity was markedly reduced (50-60%) in the hippocampus of all demented brains. The number of muscarinic cholinergic receptors was reduced only in the MID and AD/MID brains. No significant difference in substance P-like immunoreactivity was measured in 4 regions of AD brains in comparison to controls. In the combined MID plus AD/MID groups a significant reduction in substance P-like immunoreactivity (-35%) was measured in the hippocampus while no change was found in the frontal cortex, amygdala and caudate nucleus. The findings support the assumption of differences in selectivity of damage between AD and AD/MID, MID.
对9例阿尔茨海默型老年性痴呆(AD)患者、4例多发梗死性痴呆(MID)患者、6例混合型痴呆(AD/MID)患者以及9名对照者的大脑进行了P物质样免疫反应性、胆碱乙酰转移酶(ChAT)活性和毒蕈碱型胆碱能受体检测。所有痴呆患者大脑海马区的ChAT活性均显著降低(50%-60%)。仅MID和AD/MID患者大脑中的毒蕈碱型胆碱能受体数量减少。与对照者相比,AD患者大脑4个区域的P物质样免疫反应性未测得显著差异。在MID与AD/MID合并组中,海马区的P物质样免疫反应性显著降低(-35%),而额叶皮质、杏仁核和尾状核未发现变化。这些发现支持了AD与AD/MID、MID之间损伤选择性存在差异的假设。